#99 Covid – Treatment vs Vaccine

Distorted Narrative

At the age of reason, usually around seven years old, children can determine the difference between the truth and a fabrication/distortion of the truth. So then, why do adults accept fabrication and distortion?

Are they bullied by the supporters of the official version that refuse to discuss conflicting opinions? Or is it fear of being labeled a conspiracy theorist, dog-whistle language for a fool, an evil person, a terrorist?

The government has not educated the public on the limitations of vaccines. Vaccines appear to offer some level of protection. But we continue to hear, wear the mask. Both vaccinated people and unvaccinated people spread covid. The pandemic of the unvaccinated narrative is false. It is a pandemic spread by both the vaccinated and the unvaccinated.

Anthony Fauci and his minions do not recognize that many unvaccinated and vaccinated Americans want therapeutic alternatives. The “trust me and take the vaccine” narrative has worn thin. Covid infections and variant infections of the vaccinated demonstrate a failure of the vaccine. Even the spin that vaccines prevent symptoms and death is not conclusive.

The only conclusion to be made is that the government is continuing to double or triple down on coerced vaccination policy. This policy has negatively influenced the research and development of other therapies to fight covid.

Covid and HIV

For the past 25+ years, Fauci has preferred respond to pandemics by vaccines from HIV through COVID-19. His singular focus on vaccines slowed the development of effective therapeutics in HIV. Are we repeating history?

COVID-19 vaccines, their availability, and the overhyped effectiveness have prevented further development of alternative treatments for covid. Fauci has set a course very familiar to those familiar with HIV in the 1990s. Friends and families of AID victims may remember that an over-investment of vaccines research slowed the development of much more effective therapeutics in HIV. Like leronlimab/PRO 140 and the advancement of Highly Active Antiretroviral Therapy (HAART).

Ignored Alternatives

The government spent $12 billion on vaccines in 2020 through Operation Warp Speed while therapeutics were underfunded. All it would have taken is a few billion dollars to fund and expedite the manufacturing of a wide range of therapeutics to save lives, reduce the symptoms of covid and the fear of getting sick. Washington spent $2.3 trillion in stimulus due to the widespread shutdowns as therapeutics took the back seat. What a deal!

Vaccine makers were provided money and given special treatment in the clinical trial approval process. Therapeutic choices were limited because they conflicted with the vaccine-for-all policy. Tollovir and leronlimab are existing drugs that suppress the cytokine storm throughout the lifecycle of the virus.

Antiviral Therapy

Currently, big pharma is turning to antiviral therapies because the vaccines are failing to put the nail in the COVID-19 coffin. Pfizer, Merck, Shionogi, and others are now racing to develop better and more convenient antivirals. Antiviral therapy uses protease inhibitors to help hospitalized patients lower inflammation quickly to avoid entering the cytokine storm phase of the disease. These drugs work well in the early stage of the disease. More widespread use could make an impact on flattening the curve. Remember that catchy phase?

In an October 1, 2021 press release, Merck announced an easy-to-take, oral antiviral pill to treat covid-19. Pharmaceutical giant Merck announced that in an international clinical trial, molnupiravir reduced the risk of hospitalization and death by nearly half among higher-risk people diagnosed with a mild or moderate illness. The company said it would seek regulatory approval as soon as possible, meaning further delay for the United States having an anti-coronavirus pill. No Operation Warp Speed here.

Monoclonal Antibodies

The FDA authorized monoclonal antibody drugs from Regeneron and Eli Lilly in November 2020. Recently they have attracted more attention as the Delta variant of the virus that causes COVID-19 surges across the U.S. In other words, they have moved to the forefront due to the ineffectiveness of the vaccine.

Monoclonal antibodies boost the immune system after infection, speeding up your immune response to prevent COVID-19 from getting worse. Monoclonal antibodies target and neutralize the virus. When the antibodies bind to the spike protein, they block the virus from entering other body cells. They prevent severe symptoms that require hospitalization. When exposed to covid, monoclonal antibodies can fend off the virus to prevent them from becoming sick in the first place.

A monoclonal antibodies study of nearly 1000 people who lived or worked in U.S. nursing homes received either a single infusion of Eli Lilly’s antibody-containing four times the dose used for therapeutic purposes—or a placebo. In a press release, January 21, 2021, the company announced that the antibody reduced the risk of becoming ill with COVID-19 in the following eight weeks by 57%.

Among nursing home residents, who made up about one-third of the trial participants, the risk of COVID-19 illness dropped by 80%. Only four COVID-19–related deaths occurred in the study, and all were in nursing home residents in the placebo group.

Regeneron clinical trials of a different monoclonal antibody treatment using casirivimab and imdevimab reduced COVID-19-related hospitalization or deaths in high-risk patients by about 70%. And when given to an exposed person, someone living with an infected person, monoclonal antibodies reduced their risk of developing an infection with symptoms by 80%.

There are a few issues that surround monoclonal antibody treatment. Monoclonal antibodies treatment must begin within the first ten days of symptoms. Monoclonal antibodies are effective for about a month. Monoclonal antibodies were authorized as an IV and given at infusion centers making this therapy a bit cumbersome. However, a recent study indicates that an injection into the belly can also be effective.

Patients have to qualify for monoclonal antibodies. Many doctors are not very experienced with this treatment. Authorized uses for monoclonal antibodies may include: being the President of the U.S.; be classified as a high-risk person; test positive for COVID-19; have had symptoms for fewer than ten days; not be hospitalized, or not on oxygen because of COVID-19.

The deal-breaker appears to be that monoclonal antibodies might undermine the effectiveness of the sacred vaccines. Two vaccines authorized in the United States contain mRNA that directs the body cells to make the surface protein, spike, of SARS-CoV-2 acting as a trigger to the immune system to produce antibodies. Because the monoclonal antibodies target the coronavirus spike protein, there is concern that they could bind to the protein made by the mRNA vaccine, thus stopping the vaccine from functioning.

Conclusion

Has Fauci’s dedication to the vaccines suppressed treatment, destabilized the approval process of new therapy drugs, left therapeutics to fend for themselves, and contributed to a failed strategy? Have there been needless death? Has the national narrative enhanced fear? When did getting sick from covid become equated to death?

Gambling with human life is unacceptable. The combination of antiviral therapy and monoclonal antibody drugs may force us to look differently at treatment vs. vaccines. The loss of human life as a result of a failed strategy is criminal. Will anybody be held responsible?

Probably not. Only skeptics are held responsible.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s